Complementary or Alternative Medicine Practices Used by Women at Increased Risk for Breast Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00020098|
Recruitment Status : Completed
First Posted : February 27, 2004
Last Update Posted : March 29, 2012
RATIONALE: Increasing knowledge about the complementary or alternative medicine practices used by women who are at increased risk for breast cancer may provide useful information for planning breast-cancer-prevention strategies.
PURPOSE: Clinical trial to determine how many women who are at increased risk for breast cancer use complementary or alternative medicine.
|Condition or disease||Intervention/treatment|
|Breast Cancer||Procedure: evaluation of cancer risk factors|
OBJECTIVES: I. Determine the prevalence of complementary or alternative medicine (CAM) practices among adult women who are enrolled in the Risk Assessment Clinic at the National Naval Medical Center Breast Care Center and are found to be at increased risk for developing breast cancer. II. Correlate the use of CAM with individual risk for breast cancer. III. Define the types of CAM practices used by this study population. IV. Identify reasons why this study population is using CAM.
OUTLINE: Patients are stratified according to prevalence of complementary and alternative medicine practices (enteral/parenteral vs psychologic/neurologic). Patients complete a Personal Risk Assessment form, pre-test/post-test knowledge questionnaires, and a survey questionnaire.
PROJECTED ACCRUAL: A total of 102 patients will be accrued for this study within approximately 2 years.
|Study Type :||Interventional (Clinical Trial)|
|Official Title:||Use of Complementary or Alternative Medicine Practices by Women at Increased Risk for Breast Cancer|
|Study Start Date :||June 2000|
|Study Completion Date :||September 2001|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00020098
|United States, Maryland|
|National Naval Medical Center|
|Bethesda, Maryland, United States, 20889-5000|
|Bethesda, Maryland, United States, 20892|
|Study Chair:||Paula Glauber, RN||National Cancer Institute (NCI)|